Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors

BACKGROUND: High‐dose chemotherapy (HDCT) with TI‐CE regimen is a valid option for the treatment of relapsed advanced germ cell tumors (GCT). We report a phase II trial with therapeutic drug monitoring of carboplatin for optimizing area under the curve (AUC) of this drug. METHODS: Patients with unfa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chevreau, Christine, Massard, Christophe, Flechon, Aude, Delva, Rémy, Gravis, Gwenaëlle, Lotz, Jean‐Pierre, Bay, Jacques‐Olivier, Gross‐Goupil, Marine, Fizazi, Karim, Mourey, Loïc, Paci, Angelo, Guitton, Jérôme, Thomas, Fabienne, Lelièvre, Bénédicte, Ciccolini, Joseph, Moeung, Sotheara, Gallois, Yohan, Olivier, Pascale, Culine, Stéphane, Filleron, Thomas, Chatelut, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982623/
https://www.ncbi.nlm.nih.gov/pubmed/33675184
http://dx.doi.org/10.1002/cam4.3687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982623/
https://www.ncbi.nlm.nih.gov/pubmed/33675184
http://dx.doi.org/10.1002/cam4.3687

Ejemplares similares